Evidence map›Paper›PMID 23344474›Full record

Trial reportKidney international2013

Effect of frequent hemodialysis on residual kidney function.

John T Daugirdas, Tom Greene, Michael V Rocco, George A Kaysen, Thomas A Depner, Nathan W Levin, Glenn M Chertow, Daniel B Ornt, Jochen G Raimann, Brett Larive and 2 more

4 registry-linked trialsAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Kidney international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 88 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00264758 phase2 / phase3completednot on this map

Frequent Hemodialysis Network: Daily Trial

TypeinterventionalSponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Ran2006 to 2010Enrolled245ConditionsEnd Stage Renal DiseaseArmsConventional hemodialysis, Frequent hemodialysis
NCT03239808 naactive not recruitingnot on this mapstarted 2018, after this paper: background citation

Assessment of the Incremental Haemodialysis Security and Effectiveness in Incident Patients

TypeinterventionalSponsorFundación para la Formación e Investigación de los Profesionales de la Salud de ExtremaduraRan2018 to 2025Enrolled152ConditionsRenal Disease, End-StageArmsIncremental haemodialysis, Conventional haemodialysis
NCT03994133 unknown statusnot on this mapstarted 2019, after this paper: background citation

Contribution of Body Composition Monitor (BCM) Among Patients Using Daily Home Dialysis With Low Dialysate Flow : French Study Cohort

TypeobservationalSponsorUniversity Hospital, CaenRan2019 to 2020Enrolled85ConditionsChronic Kidney Disease Requiring Chronic Dialysis, Hemodialysis, Home, Electric ImpedanceArmsMeasurement of the hydration state by bio-impedance spectroscopy
NCT06243900 unknown statusnot on this mapstarted 2024, after this paper: background citation

NIRS: a Tool for the Diagnosis of Residual Renal Function Injury in Hemodialysis Patients

TypeobservationalSponsorYuanjun YangRan2024 to 2026Enrolled30ConditionsEnd-stage Renal Disease (ESRD)
3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Peritoneal dialysis versus haemodialysis for people commencing dialysis.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. Interventions for fatigue in people with kidney failure requiring dialysis.The Cochrane database of systematic reviews · 2023
    Pooled it
  4. Guideline
  5. Guideline
  6. Pooled it
  7. Home versus in-centre haemodialysis for end-stage kidney disease.The Cochrane database of systematic reviews · 2014
    Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Creatinine generation from kinetic modeling with or without postdialysis serum creatinine measurement: results from the HEMO study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2017
    Trial
  13. A Trial of Extending Hemodialysis Hours and Quality of Life.Journal of the American Society of Nephrology : JASN · 2017
    Trial
  14. Long-Term Effects of Frequent In-Center Hemodialysis.Journal of the American Society of Nephrology : JASN · 2016
    Trial
  15. Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2015
    Trial
  16. Trial
  17. Trial
  18. Review
  19. Review
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

John T DaugirdasDepartment of Medicine, University of Illinois College of Medicine, Chicago, Illinois 60527, USA. jtdaugir@uic.edu
Tom Greene
Michael V Rocco
George A Kaysen
Thomas A Depner
Nathan W Levin
Glenn M Chertow
Daniel B Ornt
Jochen G Raimann
Brett Larive
Alan S Kliger
FHN Trial Group

Funding

Frequent Hemodialysis Network Data Coordinating CenterU01DK066597 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI BECK, GERALD J · 2003 to 2010
$8.9M
NIDDK NIH HHS U01 DK066597
6 · The paper itself

Abstract

Frequent hemodialysis can alter volume status, blood pressure, and the concentration of osmotically active solutes, each of which might affect residual kidney function (RKF). In the Frequent Hemodialysis Network Daily and Nocturnal Trials, we examined the effects of assignment to six compared with three-times-per-week hemodialysis on follow-up RKF. In both trials, baseline RKF was inversely correlated with number of years since onset of ESRD. In the Nocturnal Trial, 63 participants had non-zero RKF at baseline (mean urine volume 0.76 liter/day, urea clearance 2.3 ml/min, and creatinine clearance 4.7 ml/min). In those assigned to frequent nocturnal dialysis, these indices were all significantly lower at month 4 and were mostly so at month 12 compared with controls. In the frequent dialysis group, urine volume had declined to zero in 52% and 67% of patients at months 4 and 12, respectively, compared with 18% and 36% in controls. In the Daily Trial, 83 patients had non-zero RKF at baseline (mean urine volume 0.43 liter/day, urea clearance 1.2 ml/min, and creatinine clearance 2.7 ml/min). Here, treatment assignment did not significantly influence follow-up levels of the measured indices, although the range in baseline RKF was narrower, potentially limiting power to detect differences. Thus, frequent nocturnal hemodialysis appears to promote a more rapid loss of RKF, the mechanism of which remains to be determined. Whether RKF also declines with frequent daily treatment could not be determined.

Indexed as

AdultAgedBiomarkersBlood Urea NitrogenCreatinineFemaleHumansKidneyKidney DiseasesMaleMiddle AgedProspective StudiesRenal DialysisTime FactorsTreatment OutcomeUnited StatesBiomarkersCreatinineUrea

Identifiers

PMID23344474
PMCPMC3855839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.